In the last 12 months, precision healthcare in the Asia-Pacific region has seen a surge in technology advancements, including NGS and laboratory developed tests, approvals such as a companion diagnostic test for lung cancer, and evolving regulations throughout the region.

The World Companion Diagnostics & Liquid Biopsy Summit APAC has been put together to provide a dedicated forum for key stakeholders from biopharma, diagnostic providers and leading academics to overcome critical challenges in liquid biopsy and companion diagnostic (CDx) testing.

• Where: Conrad Centennial, Singapore
• When: November 13-14, 2024
• Who: 100+ precision medicine experts from across the APAC region and wider globe

Download the event agenda here: https://ter.li/3qxsp8

This unique and important forum is uniting experts from Singapore, Australia, China, Japan, Taiwan, the USA and more to create a comprehensive framework for successful drug-companion diagnostic co-development and robust biomarker testing to accelerate patient access to personalized healthcare for improved outcomes in the APAC market.

This conference is FREE* to attend for drug developers and academics, see the website for full terms and conditions here: https://ter.li/ewpxoe